Innoviva, Inc.
Index- P/E7.46 EPS (ttm)2.13 Insider Own0.90% Shs Outstand69.54M Perf Week2.32%
Market Cap1.09B Forward P/E7.04 EPS next Y2.26 Insider Trans0.00% Shs Float69.11M Perf Month-12.96%
Income187.50M PEG0.39 EPS next Q0.46 Inst Own- Short Float17.86% Perf Quarter-20.21%
Sales396.40M P/S2.74 EPS this Y42.20% Inst Trans1.66% Short Ratio10.65 Perf Half Y-7.77%
Book/sh5.56 P/B2.86 EPS next Y15.31% ROA20.20% Target Price20.50 Perf Year19.44%
Cash/sh- P/C- EPS next 5Y19.34% ROE48.90% 52W Range11.90 - 20.71 Perf YTD-7.77%
Dividend- P/FCF- EPS past 5Y42.80% ROI36.90% 52W High-23.16% Beta0.53
Dividend %- Quick Ratio2.90 Sales past 5Y24.00% Gross Margin- 52W Low33.70% ATR0.55
Employees5 Current Ratio2.90 Sales Q/Q5.40% Oper. Margin89.00% RSI (14)39.07 Volatility2.60% 3.44%
OptionableYes Debt/Eq1.39 EPS Q/Q-76.70% Profit Margin47.30% Rel Volume0.48 Prev Close15.95
ShortableYes LT Debt/Eq1.15 EarningsFeb 09 AMC Payout0.00% Avg Volume1.16M Price15.91
Recom4.00 SMA20-3.03% SMA50-11.72% SMA200-6.98% Volume562,891 Change-0.25%
Nov-20-17Initiated Deutsche Bank Hold $13
Apr-27-22 06:45PM  
Apr-25-22 09:40AM  
Apr-20-22 03:01PM  
Apr-19-22 07:45AM  
Apr-11-22 12:52PM  
Apr-08-22 12:26PM  
Apr-07-22 08:06AM  
Apr-06-22 11:58AM  
Apr-01-22 09:40AM  
Mar-31-22 04:05PM  
Mar-30-22 12:28PM  
Mar-29-22 04:26PM  
Mar-24-22 01:39PM  
Mar-16-22 09:00AM  
Mar-14-22 12:31PM  
Mar-10-22 10:49AM  
Mar-05-22 11:23AM  
Mar-04-22 07:35AM  
Mar-03-22 07:45AM  
Mar-02-22 07:30AM  
Feb-24-22 12:20PM  
Feb-11-22 07:37AM  
Feb-09-22 04:45PM  
Jan-27-22 09:38AM  
Dec-23-21 08:52AM  
Dec-16-21 11:38PM  
Oct-27-21 04:05PM  
Oct-12-21 01:43PM  
Oct-08-21 03:28PM  
Jul-28-21 04:05PM  
Jul-16-21 03:58AM  
Jun-10-21 04:44AM  
Jun-08-21 03:16PM  
May-20-21 09:40AM  
May-05-21 04:05PM  
May-03-21 04:05PM  
Apr-28-21 04:05PM  
Mar-17-21 04:01PM  
Mar-08-21 07:03AM  
Mar-05-21 01:06AM  
Feb-03-21 05:44PM  
Feb-02-21 08:52AM  
Jan-27-21 07:01AM  
Jan-26-21 05:50PM  
Jan-05-21 10:37AM  
Jan-04-21 10:11AM  
Jan-01-21 11:50AM  
Dec-29-20 01:09PM  
Dec-28-20 11:38AM  
Dec-24-20 09:21AM  
Dec-18-20 09:30PM  
Dec-16-20 11:50AM  
Dec-10-20 08:42AM  
Dec-09-20 11:44AM  
Dec-07-20 10:07AM  
Dec-03-20 11:17AM  
Dec-02-20 07:48AM  
Dec-01-20 08:29AM  
Nov-30-20 11:50AM  
Nov-27-20 08:29AM  
Nov-24-20 09:08AM  
Nov-19-20 08:20AM  
Nov-17-20 08:23AM  
Nov-02-20 10:23AM  
Oct-28-20 04:30PM  
Oct-13-20 03:28PM  
Oct-12-20 10:19AM  
Sep-25-20 07:09AM  
Sep-10-20 11:06AM  
Sep-09-20 06:45PM  
Sep-03-20 08:30AM  
Aug-28-20 08:00AM  
Aug-24-20 11:35AM  
Aug-04-20 11:33AM  
Jul-29-20 04:05PM  
Jul-27-20 02:32PM  
Jul-20-20 11:17AM  
Jul-06-20 12:58PM  
Jun-23-20 08:34PM  
Jun-11-20 04:05PM  
Jun-09-20 05:50PM  
Jun-08-20 11:50AM  
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Innoviva, Inc.DirectorMar 31Buy5.005,385,20826,926,04016,365,969Apr 01 04:52 PM
Innoviva, Inc.DirectorFeb 09Buy5.003,614,79218,073,96010,980,761Feb 11 06:56 PM
Innoviva, Inc.DirectorOct 29Buy3.301,212,1224,000,0037,365,969Nov 01 02:20 PM
Zhen MarianneChief Accounting OfficerAug 19Sale16.022,80244,88836,493Aug 23 05:02 PM
Bickerstaff GeorgeDirectorMay 24Buy13.4610,000134,619124,560May 25 06:44 PM
Bickerstaff GeorgeDirectorMay 21Buy12.9710,000129,670114,560May 25 06:44 PM